136 related articles for article (PubMed ID: 26861061)
1. Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.
Zhang J; Shi Z; Nan Y; Li M
Int Urol Nephrol; 2016 May; 48(5):711-6. PubMed ID: 26861061
[TBL] [Abstract][Full Text] [Related]
2. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer.
Liu L; Liu Y; Zhuang C; Xu W; Fu X; Lv Z; Wu H; Mou L; Zhao G; Cai Z; Huang W
Tumour Biol; 2015 Sep; 36(10):7685-9. PubMed ID: 25934337
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
[TBL] [Abstract][Full Text] [Related]
4. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
5. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Nie L; Gui Y; Cai Z
Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA linc00346 promotes the malignant phenotypes of bladder cancer.
Ye T; Ding W; Wang N; Huang H; Pan Y; Wei A
Biochem Biophys Res Commun; 2017 Sep; 491(1):79-84. PubMed ID: 28705739
[TBL] [Abstract][Full Text] [Related]
7. lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion.
Zhang C; Wang W; Lin J; Xiao J; Tian Y
Int Braz J Urol; 2019; 45(3):549-559. PubMed ID: 31038865
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
[TBL] [Abstract][Full Text] [Related]
10. Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q
Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CRNDE promotes the progression of bladder cancer.
Cheng J; Chen J; Zhang X; Mei H; Wang F; Cai Z
Biomed Pharmacother; 2018 Mar; 99():638-644. PubMed ID: 29710461
[TBL] [Abstract][Full Text] [Related]
13. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
Chen M; Li J; Zhuang C; Cai Z
Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695
[TBL] [Abstract][Full Text] [Related]
14. Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer.
Hu X; Feng H; Huang H; Gu W; Fang Q; Xie Y; Qin C; Hu X
Technol Cancer Res Treat; 2019 Jan; 18():1533033819846638. PubMed ID: 31311442
[TBL] [Abstract][Full Text] [Related]
15. Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.
Zhuang C; Li J; Liu Y; Chen M; Yuan J; Fu X; Zhan Y; Liu L; Lin J; Zhou Q; Xu W; Zhao G; Cai Z; Huang W
Oncotarget; 2015 Dec; 6(38):41194-203. PubMed ID: 26517688
[TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Apr; 107(5):555-9. PubMed ID: 22961206
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed long noncoding RNAs in bladder cancer.
Peter S; Borkowska E; Drayton RM; Rakhit CP; Noon A; Chen W; Catto JW
Clin Cancer Res; 2014 Oct; 20(20):5311-21. PubMed ID: 25165097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
